Skip to content
Monday, November 9, 2026
Platinum Vault Online

Zimbabwe Rejects ‘Unbalanced’ American Healthcare Assistance Deal Because of Data Fears

Health aid image
The offered American financial assistance would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a major US health deal worth $367m (£272m) spanning five years because of Washington's insistence on sensitive biological samples.

This move became public after a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".

A government representative later explained that the United States was seeking health data for research and commercial gain while was not willing to guarantee the benefits from any future treatments.

"We must now begin the challenging and unfortunate task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for continued talks to reach a deal suitable to both sides so the nation's critical HIV treatment initiative can be sustained.

Wider Context

This development follows a similar situation in Kenya, where a high court suspended a similar deal with the US following legal challenges were filed about the safety of citizens' medical information.

After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government deals to boost openness and accountability.

Based on statements, Sixteen nations in Africa have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Agreement

This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana argued the arrangement was "unfair".

"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"In essence, our nation would supply the basic resources for medical research without any certainty that the final treatments would be accessible to our population should a future health crisis arise."

Sovereignty and Global Health

He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending systems already established via the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.

"This system is designed to guarantee that when a nation provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

These objections over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We are open to further discussions with our American counterparts on how subsequent co-operation might be arranged in a way that honours the independence and dignity of each country."

Medical Community Reaction

A leading public health body said it recognised the official position, but urged that negotiations should continue since much of the nation's HIV programmes were funded by external financing.

"If technical issues exist, such as those relating to information security or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.

This impasse highlights the continuing debate between accepting vital foreign assistance and safeguarding local interests in an ever more data-driven world.

Written by

Laura Gutierrez

Financial analyst and luxury asset specialist with over a decade of experience in precious metals and alternative investments.

Platinum Vault Online

Type to search articles.